MARIE-CHRISTINE NADON: Open Payments
NPI 1093426306 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,499 in 102 payments from 18 companies in 2025. Trend: 2023 $77 · 2024 $797 · 2025 $2,499
Food & beverage: $2,499
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $670 |
| GlaxoSmithKline, LLC. | 23 | $460 |
| Regeneron Healthcare Solutions, Inc. | 9 | $254 |
| Novartis Pharmaceuticals Corporation | 12 | $219 |
| ABBVIE INC. | 8 | $190 |
| Lilly USA, LLC | 4 | $93 |
| Amgen Inc. | 4 | $88 |
| Grifols USA, LLC | 4 | $85 |
| CSL Behring | 3 | $83 |
| Genentech USA, Inc. | 3 | $76 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, AIRSUPRA, RINVOQ, EBGLYSS, Xembify, Hizentra.
Industry payments across MA — which companies pay providers there.
